"Designing Growth Strategies is in our DNA"

China Pharmaceuticals Market Size, Share & Industry Analysis, By Type (Drugs and Vaccines, By Disease Indication (Oncology, Diabetes, Infectious, Cardiovascular, Neurology & Psychiatry, Respiratory, Renal, Obesity, Autoimmune, Ophthalmic, Gastrointestinal, Dermatology, Hematology/Blood, Liver/Hepatology, Genetic, Hormonal/Endocrine, Women’s Health, Reproductive, & Allergies), By Drug Type (Biologics & Biosimilars, and Small Molecules/Conventional Drugs), By Route of Administration (Oral, Parenteral, Topical, & Inhalation), By Age Group, By Distribution Channel, and Country Forecast, 2025-2032

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI113976

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Trends
  4. Key Insights
    1. New Product Launches, By Key Players
    2. Key Industry Developments (Mergers, Acquisitions & Partnerships, etc.)
    3. Pipeline Analysis, By Key Players
    4. Prevalence/Incidence of Key Diseases in China
    5. Regolatory Framework in China
    6. Reimbursement Scenario in China
  5. China Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Drugs
        1. Prescription
        2. OTC
      2. Vaccines
        1. Bacterial
        2. Viral
      3. Market Analysis, Insights and Forecast – By Disease Indication
        1. Oncology
        2. Diabetes
        3. Infectious
        4. Cardiovascolar
        5. Neurology & Psychiatry
        6. Respiratory
        7. Renal
        8. Obesity
        9. Autoimmune
        10. Ophthalmic
        11. Gastrointestinal
        12. Dermatology
        13. Hematology/Blood
        14. Liver/Hepatology
        15. Genetic
        16. Hormonal/Endocrine
        17. Women’s Health
        18. Reproductive
        19. Allergies
        20. Others
      4. Market Analysis, Insights and Forecast – By Drug Type
        1. Biologics & Biosimilars
          1. Antibodies
            1. Monoclonal Antibodies (mAbs)
            2. Bispecific Antibodies
            3. Antibody-Drug Conjugates (ADCs)
            4. Others
          2. Vaccines
          3. Peptides/Peptide-Drug Conjugates (PDCs)
          4. Others
        2. Small Molecoles/Conventional Drugs
      5. Market Analysis, Insights and Forecast – By Route of Administration
        1. Oral
        2. Parenteral
        3. Topical
        4. Inhalation
        5. Others
      6. Market Analysis, Insights and Forecast – By Age Group
        1. Pediatric
        2. Adolts
      7. Market Analysis, Insights and Forecast – By Distribution Channel
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  6. Competitive Analysis
    1. China Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Sinopharm Group
      2. Shanghai Pharmaceuticals Holding Co., Ltd.
      3. China Resources Pharmaceutical Group
      4. Yunnan Baiyao Group
      5. Wuxi Biologics
      6. Jiangsu Hengrui Medicine
      7. Other Prominent Players
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Trends
  4. Key Insights
    1. New Product Launches, By Key Players
    2. Key Industry Developments (Mergers, Acquisitions & Partnerships, etc.)
    3. Pipeline Analysis, By Key Players
    4. Prevalence/Incidence of Key Diseases in China
    5. Regolatory Framework in China
    6. Reimbursement Scenario in China
  5. China Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Drugs
        1. Prescription
        2. OTC
      2. Vaccines
        1. Bacterial
        2. Viral
      3. Market Analysis, Insights and Forecast – By Disease Indication
        1. Oncology
        2. Diabetes
        3. Infectious
        4. Cardiovascolar
        5. Neurology & Psychiatry
        6. Respiratory
        7. Renal
        8. Obesity
        9. Autoimmune
        10. Ophthalmic
        11. Gastrointestinal
        12. Dermatology
        13. Hematology/Blood
        14. Liver/Hepatology
        15. Genetic
        16. Hormonal/Endocrine
        17. Women’s Health
        18. Reproductive
        19. Allergies
        20. Others
      4. Market Analysis, Insights and Forecast – By Drug Type
        1. Biologics & Biosimilars
          1. Antibodies
            1. Monoclonal Antibodies (mAbs)
            2. Bispecific Antibodies
            3. Antibody-Drug Conjugates (ADCs)
            4. Others
          2. Vaccines
          3. Peptides/Peptide-Drug Conjugates (PDCs)
          4. Others
        2. Small Molecoles/Conventional Drugs
      5. Market Analysis, Insights and Forecast – By Route of Administration
        1. Oral
        2. Parenteral
        3. Topical
        4. Inhalation
        5. Others
      6. Market Analysis, Insights and Forecast – By Age Group
        1. Pediatric
        2. Adolts
      7. Market Analysis, Insights and Forecast – By Distribution Channel
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  6. Competitive Analysis
    1. China Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Sinopharm Group
      2. Shanghai Pharmaceuticals Holding Co., Ltd.
      3. China Resources Pharmaceutical Group
      4. Yunnan Baiyao Group
      5. Wuxi Biologics
      6. Jiangsu Hengrui Medicine
      7. Other Prominent Players
Read Less

Figure 1: China Pharmaceuticals Market Revenue Breakdown (USD Billion, %), By Type, 2024 & 2032

Figure 2: China Pharmaceuticals Market Value Share (%), by Type, 2024 & 2032

Figure 3: China Pharmaceuticals Market Value Share (%), by Indication, 2024 & 2032

Figure 4: China Pharmaceuticals Market Value Share (%), by Drug Type, 2024 & 2032

Figure 5: China Pharmaceuticals Market Value Share (%), by Route of Administration, 2024 & 2032

Figure 6: China Pharmaceuticals Market Value Share (%), by Age Group, 2024 & 2032

Figure 7: China Pharmaceuticals Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 8: China Pharmaceuticals Market Share (%), By Company, 2024

Table 1: China Pharmaceuticals Market Revenue (USD Billion) Forecast, by Type, 2019–2032

Table 2: China Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drugs, 2019–2032

Table 3: China Pharmaceuticals Market Revenue (USD Billion) Forecast, by Vaccines, 2019–2032

Table 4: China Pharmaceuticals Market Revenue (USD Billion) Forecast, by Disease Indicarion, 2019–2032

Table 5: China Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drug Type, 2019–2032

Table 6: China Pharmaceuticals Market Revenue (USD Billion) Forecast, by Biologics & Biosimilars, 2019–2032

Table 7: China Pharmaceuticals Market Revenue (USD Billion) Forecast, by Antibodies, 2019–2032

Table 8: China Pharmaceuticals Market Revenue (USD Billion) Forecast, by Route of Administration, 2019–2032

Table 9: China Pharmaceuticals Market Revenue (USD Billion) Forecast, by Age Group, 2019–2032

Table 10: China Pharmaceuticals Market Revenue (USD Billion) Forecast, by Distribution Channel, 2019–2032

China Pharmaceuticals Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 130
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports